Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

Li Roger; Spiess Philippe E.; Gilbert Scott M.; Necchi Andrea

首页> 外文期刊>European urology >Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

【24h】

Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

机译：对于肌肉侵袭性膀胱癌的个性化新辅助治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European urology》 |2019年第1期|共3页
作者
Li Roger; Spiess Philippe E.; Gilbert Scott M.; Necchi Andrea;
展开▼
作者单位

H Lee Moffitt Canc Ctr &

Res Inst Dept Genitourinary Oncol 12902 USF Magnolia Dr Tampa FL 33612;

H Lee Moffitt Canc Ctr &

Res Inst Dept Genitourinary Oncol 12902 USF Magnolia Dr Tampa FL 33612;

H Lee Moffitt Canc Ctr &

Res Inst Dept Genitourinary Oncol 12902 USF Magnolia Dr Tampa FL 33612;

Fdn IRCCS Ist Nazl Tumori Dept Med Oncol Milan Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类泌尿科学（泌尿生殖系疾病）;
关键词

相似文献

外文文献
中文文献
专利

1. Re: Roger Li, Philippe E. Spiess, Scott M. Gilbert, Andrea Necchi. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer. Eur Urol 2019;76:4-6 [J] . Yang Yubo, Wei Xin, Han Ping European urology . 2019,第2期

机译：Re：Roger Li，Philippe E. Spiess，Scott M.Gilbert，Andrea Necchi。对于肌肉侵袭性膀胱癌的个性化新辅助治疗。 EUR UROL 2019; 76：4-6
2. Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer [J] . Li Roger, Spiess Philippe E., Gilbert Scott M., European urology . 2019,第1期

机译：对于肌肉侵袭性膀胱癌的个性化新辅助治疗
3. Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer [J] . Khaled Ajib, Michael C. Tjong, Guan Hee Tan, Canadian Urological Association Journal . 2020,第12期

机译：Neoadjuvant化疗的加拿大经验对肌肉侵袭性膀胱癌进行染色术治疗患者膀胱复发
4. Predictive Biomarkers for Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer: A survey [C] . Hisham Abdeltawab, Fahmi Khalifa, Mohammed Ghazal, IEEE International Symposium on Signal Processing and Information Technology . 2018

机译：肌肉浸润性膀胱癌新辅助化疗反应的预测性生物标志物：一项调查
5. Molecular Subtyping to Stratify the Treatment of Muscle-Invasive Bladder Cancer: A Cost-Effectiveness Analysis [D] . Magee, Diana E. 2021

机译：分子亚型分析肌肉侵袭性膀胱癌的治疗：成本效益分析
6. Canadian experience of neoadjuvant chemotherapy on bladder recurrences in patients managed with trimodal therapy for muscle-invasive bladder cancer [O] . Khaled Ajib, Michael C. Tjong, Guan Hee Tan, 2020

机译：Neoadjuvant化疗的加拿大经验对肌肉侵袭性膀胱癌进行染色术治疗患者膀胱复发
7. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy [O] . Jinbo Chen, Long Wang, Yunhua Tang, 2016

机译：Maspin增强顺铂对膀胱癌T24和5637细胞的化学敏感性，并与接受基于顺铂的新辅助化疗的肌肉浸润性膀胱癌患者的预后相关

Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

著录项

相似文献

相关主题

期刊订阅